Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 1
1996 3
1998 2
1999 3
2000 6
2001 1
2002 1
2004 4
2005 2
2006 5
2007 1
2008 4
2009 3
2010 5
2011 5
2012 5
2013 6
2014 8
2015 6
2016 9
2017 6
2018 6
2019 2
2020 5
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Results by year
Filters applied: . Clear all
Page 1
Molecular Pathogenesis of Cholangiocarcinoma.
Labib PL, Goodchild G, Pereira SP. Labib PL, et al. BMC Cancer. 2019 Feb 28;19(1):185. doi: 10.1186/s12885-019-5391-0. BMC Cancer. 2019. PMID: 30819129 Free PMC article. Review.
RISK FACTORS FOR CHOLANGIOCARCINOGENESIS: Cholestatic liver diseases (e.g. primary sclerosing cholangitis and fibropolycystic liver diseases), liver cirrhosis, and biliary stone disease all increase the risk of cholangiocarcinoma. ...Other risk factors includ …
RISK FACTORS FOR CHOLANGIOCARCINOGENESIS: Cholestatic liver diseases (e.g. primary sclerosing cholangitis and fibropoly …
Association between smoking and risk of primary sclerosing cholangitis: A systematic review and meta-analysis.
Wijarnpreecha K, Panjawatanan P, Mousa OY, Cheungpasitporn W, Pungpapong S, Ungprasert P. Wijarnpreecha K, et al. United European Gastroenterol J. 2018 May;6(4):500-508. doi: 10.1177/2050640618761703. Epub 2018 Feb 21. United European Gastroenterol J. 2018. PMID: 29881604 Free PMC article.
BACKGROUND/OBJECTIVES: Studies have suggested that smokers may have a lower risk of primary sclerosing cholangitis (PSC) although the results have been inconsistent. ...
BACKGROUND/OBJECTIVES: Studies have suggested that smokers may have a lower risk of primary sclerosing cholangitis (PSC …
Risk factors for cholangiocarcinoma.
Tyson GL, El-Serag HB. Tyson GL, et al. Hepatology. 2011 Jul;54(1):173-84. doi: 10.1002/hep.24351. Hepatology. 2011. PMID: 21488076 Free PMC article. Review.
There are several established risk factors for CC, including parasitic infections, primary sclerosing cholangitis, biliary-duct cysts, hepatolithiasis, and toxins. Other less-established potential risk factors include inflammatory bowel disease, hepatitis C v …
There are several established risk factors for CC, including parasitic infections, primary sclerosing cholangitis, bili …
Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence.
Hata K, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Tanaka T, Kishikawa J, Anzai H, Watanabe T. Hata K, et al. Dig Endosc. 2017 Jan;29(1):26-34. doi: 10.1111/den.12744. Epub 2016 Nov 7. Dig Endosc. 2017. PMID: 27681447 Review.
The reported incidence of pouchitis ranges from 14% to 59%, and antibiotic therapy is the primary treatment for acute pouchitis. Chronic pouchitis includes antibiotic-dependent and refractory pouchitis. ...Reported risk factors for the development of pouchitis include pres …
The reported incidence of pouchitis ranges from 14% to 59%, and antibiotic therapy is the primary treatment for acute pouchitis. Chro …
Primary sclerosing cholangitis.
Williamson KD, Chapman RW. Williamson KD, et al. Dig Dis. 2014;32(4):438-45. doi: 10.1159/000358150. Epub 2014 Jun 23. Dig Dis. 2014. PMID: 24969292 Review.
Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease caused by diffuse inflammation and fibrosis that can involve the entire biliary tree. ...PSC is a complex genetic disorder with male predominance. Environmental predisposing factors
Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease caused by diffuse inflammation and fibrosi
Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns.
Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, Simpson AL, Jarnagin W, Klimstra DS. Sigel CS, et al. Am J Surg Pathol. 2018 Oct;42(10):1334-1345. doi: 10.1097/PAS.0000000000001118. Am J Surg Pathol. 2018. PMID: 30001234 Free PMC article.
SD was the most common (84%; 24% SD1 and 60% SD2) with lower proportions of LD (8%), and indeterminate (8%). Primary sclerosing cholangitis was rare (2%), but correlated with LD (P=0.005). Chronic hepatitis, frequent alcohol use, smoking, and steatosis …
SD was the most common (84%; 24% SD1 and 60% SD2) with lower proportions of LD (8%), and indeterminate (8%). Primary sclerosing
Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis.
Andersen IM, Tengesdal G, Lie BA, Boberg KM, Karlsen TH, Hov JR. Andersen IM, et al. Clin Gastroenterol Hepatol. 2014 Jun;12(6):1019-28. doi: 10.1016/j.cgh.2013.09.024. Epub 2013 Sep 25. Clin Gastroenterol Hepatol. 2014. PMID: 24076415

BACKGROUND & AIMS: Little is known about nongenetic risk factors for primary sclerosing cholangitis (PSC), except a possible protective effect of smoking. ...Ever daily smoking (P < .001) and being a coffee drinker at the age of 18 years

BACKGROUND & AIMS: Little is known about nongenetic risk factors for primary sclerosing cholangitis (PSC), except a …
Chronic Periaortitis: an Update.
Palmisano A, Maritati F, Vaglio A. Palmisano A, et al. Curr Rheumatol Rep. 2018 Nov 5;20(12):80. doi: 10.1007/s11926-018-0789-2. Curr Rheumatol Rep. 2018. PMID: 30397845 Review.
It can present as an isolated disease, but it can also be associated with other autoimmune and fibro-inflammatory lesions (e.g., fibrosing mediastinitis, sclerosing pancreato-cholangitis) that are part of the spectrum of IgG4-related disease. ...The pathogenesis of …
It can present as an isolated disease, but it can also be associated with other autoimmune and fibro-inflammatory lesions (e.g., fibrosing m …
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL, Bungay HK, Betts M, Forde C, Buchel O, Manganis C, Warren BF, Cummings FR, Keshav S, Travis SPL, Chapman RW. Culver EL, et al. Liver Int. 2020 Nov;40(11):2744-2757. doi: 10.1111/liv.14645. Liver Int. 2020. PMID: 32841490
BACKGROUND: Primary sclerosing cholangitis (PSC) is closely associated with inflammatory bowel disease, particularly ulcerative colitis (UC), with an increased risk of biliary and colorectal malignancy. ...Sub-clinical PSC was associated with advanced age (P …
BACKGROUND: Primary sclerosing cholangitis (PSC) is closely associated with inflammatory bowel disease, particularly ul …
Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.
Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Spalinger J, Schibli S, Petit LM, Braegger CP; Swiss IBD Cohort Study Group. Herzog D, et al. Eur J Gastroenterol Hepatol. 2018 Jun;30(6):598-607. doi: 10.1097/MEG.0000000000001072. Eur J Gastroenterol Hepatol. 2018. PMID: 29360691
Despite differences in sex, initial disease location, and smoking habits, at 10 years after the diagnosis, no difference was found regarding disease behavior in CD or regarding progression of disease extension in UC. ...However, higher rates of anemia and lower rates of ar …
Despite differences in sex, initial disease location, and smoking habits, at 10 years after the diagnosis, no difference was found re …
92 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page